TransMedics (TMDX) Deferred Taxes (2023 - 2026)

TransMedics' (TMDX) quarterly Deferred Taxes came in at $1.1 million in Q1 2026, up 989.17% quarter-over-quarter from -$120000.0 in Q4 2023.

TransMedics (TMDX) Deferred Taxes (2023 - 2026) Analysis & Trends

TransMedics' Deferred Taxes history runs 2 years deep, the most recent figure standing at $1.1 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -33.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -9.40 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 7.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 51.51 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 TransMedics 2.45 Bn 1.98 Bn 101.16 Mn 1.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.07 Mn
Dec 31, 2023 -120,000.00